Partnering with You.

Quest Diagnostics and Myriad Genetics End...

Agreement ensures continuing broad patient access to Quest's BRCAvantage™ services for evaluating genetic risk of developing breast, ovarian and other cancers
Learn More

Quest Diagnostics and CDC Expand Public...

Multi-year fee-based contract for Quest's test data and analytics expertise aims to reveal insights from national testing trends to promote guideline-based care and better outcomes for 4.4 million...
Learn More